PAGNESI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 373
AS - Asia 327
EU - Europa 295
SA - Sud America 44
AF - Africa 5
OC - Oceania 1
Totale 1.045
Nazione #
US - Stati Uniti d'America 353
IT - Italia 155
SG - Singapore 119
CN - Cina 99
HK - Hong Kong 57
SE - Svezia 49
BR - Brasile 36
GB - Regno Unito 20
DE - Germania 18
IN - India 18
PL - Polonia 15
JP - Giappone 12
MX - Messico 10
CA - Canada 9
ES - Italia 8
VN - Vietnam 7
AT - Austria 6
RU - Federazione Russa 6
FR - Francia 5
BD - Bangladesh 4
CH - Svizzera 4
FI - Finlandia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
EC - Ecuador 2
LT - Lituania 2
NL - Olanda 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TR - Turchia 2
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CO - Colombia 1
HN - Honduras 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 1.045
Città #
Ashburn 79
Singapore 68
Hong Kong 57
Milan 51
Beijing 26
New York 24
Shanghai 24
Dallas 19
Boardman 17
Orem 17
Los Angeles 16
Hefei 14
Warsaw 13
Chennai 12
Munich 12
Rome 12
Tokyo 12
Poplar 11
Brescia 10
Brooklyn 9
Denver 9
Lawrence 8
Princeton 8
Phoenix 7
Querétaro 7
Boston 6
Houston 6
Naples 6
Catania 5
Monza 5
Santa Clara 5
São Paulo 5
Bologna 4
Ho Chi Minh City 4
Ittigen 4
Manchester 4
Montreal 4
Stockholm 4
Turin 4
Washington 4
Chicago 3
Colliano 3
Guanzate 3
Johannesburg 3
Miami 3
Moscow 3
Nuremberg 3
Padua 3
Vienna 3
Vimodrone 3
Ankara 2
Atlanta 2
Bismarck 2
Buffalo 2
Cagliari 2
Campinas 2
Figino 2
Guangzhou 2
Guayaquil 2
London 2
Mareno di Piave 2
Mexico City 2
Mumbai 2
New Delhi 2
Pescara 2
Providence 2
Rockville 2
San Jose 2
Tianjin 2
Toronto 2
Verona 2
Wroclaw 2
Abidjan 1
Amman 1
Amsterdam 1
Annapolis 1
Artena 1
Augusta 1
Avondale 1
Baku 1
Bari 1
Bela Vista 1
Belo Horizonte 1
Bergamo 1
Betim 1
Birigui 1
Bo'ness 1
Borås 1
Brugherio 1
Bucaramanga 1
Calgary 1
Carney 1
Caserta 1
Cassano Magnago 1
Caxias do Sul 1
Caçador 1
Changsha 1
Charleston 1
Contagem 1
Curitiba 1
Totale 714
Nome #
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 79
Integrated clinical role of echocardiography in patients with COVID-19 68
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 67
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 61
Heart and Lung Multimodality Imaging in COVID-19 61
A novel scoring system and decisional algorithm to predict functional recovery after heart valve surgery 60
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 56
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 54
Neutrophil to lymphocyte ratio: a new preoperative predictive index of postoperative atrial fibrillation 50
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 47
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 46
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 43
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 39
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis 36
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 19
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 17
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 15
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 14
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 14
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 12
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 12
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 11
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 9
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 9
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 7
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 7
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 7
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 7
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 6
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 6
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 6
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 6
Prognostic role of mitral regurgitation in patients with advanced heart failure 6
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 6
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 6
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 6
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 6
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF 6
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 5
Characteristics, Prognosis and ESC/ERS Risk Stratification in Obese Patients with Pulmonary Arterial Hypertension (PAH) 5
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 5
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 5
2024 update in heart failure 5
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 4
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 4
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC 4
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 4
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 4
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial 4
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 4
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 4
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 4
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hope 4
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 4
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 4
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 4
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 4
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 4
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 4
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 4
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 4
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 3
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 3
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy 3
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 3
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 3
Reply to 'Malnutrition and severe heart failure in real-world study settings' 3
Ejection fraction in heart failure: just become Emperor's new clothes? 3
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 3
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 3
Diuretic De-Escalation in Response to HF Therapy: Are We Closer to Reduced Reliance on Diuretics? 3
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 3
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy 3
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 3
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 3
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 3
Lactate Values and Mortality in Patients With Cardiogenic Shock: Insights From the Altshock-2 Registry 3
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 3
Increasing Evidence Supports the Benefits of Rapid Uptitration of the Neurohormonal Blockade in HFmrEF/HFpEF Patients With AHF 3
Right ventricular thrombosis: from a case report to pathophysiology mechanisms and current treatment options 3
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 3
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial 3
Heart failure: an update from the last years and a look at the near future 3
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis 3
Organ perfusion pressure predicts outcomes in cardiogenic shock patients 3
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study 3
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure? 3
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 3
March 2021 at a glance: focus on epidemiology, prevention and COVID-19 3
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 3
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study 3
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 3
Reply to "Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients" 3
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 3
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 3
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 3
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 3
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 3
Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study 2
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 2
Totale 1.199
Categoria #
all - tutte 6.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 16 0 0 1 0 0 0
2021/202212 0 0 0 7 3 1 0 1 0 0 0 0
2022/202362 19 15 5 0 0 9 0 8 0 0 2 4
2023/202473 0 5 12 10 12 6 2 15 0 0 6 5
2024/2025230 13 11 2 6 10 31 52 31 15 17 16 26
2025/2026838 85 45 17 113 169 409 0 0 0 0 0 0
Totale 1.242